Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes.
D002478:Cells, Cultured; D003864:Depression, Chemical; D004893:Erythema Nodosum / Q000188:drug therapy; D006801:Humans; D006861:Hydrogen Peroxide / Q000097:blood*; D006878:Hydroxides / Q000037:antagonists & inhibitors / Q000097:blood*; D007918:Leprosy / Q000188:drug therapy; D009504:Neutrophils / Q000378:metabolism*; D010100:Oxygen / Q000037:antagonists & inhibitors / Q000097:blood*; D013792:Thalidomide / Q000494:pharmacology* / Q000627:therapeutic use; D015054:Zymosan / Q000494:pharmacology
D006878:Hydroxides; D013792:Thalidomide; D015054:Zymosan; D006861:Hydrogen Peroxide; D010100:Oxygen